It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The search for effective therapeutic targets in fields like regenerative medicine and cancer research has generated interest in cell fate reprogramming. This cellular reprogramming paradigm can drive cells to a desired target state from any initial state. However, methods for identifying reprogramming targets remain limited for biological systems that lack large sets of experimental data or a dynamical characterization. We present NETISCE, a novel computational tool for identifying cell fate reprogramming targets in static networks. In combination with machine learning algorithms, NETISCE estimates the attractor landscape and predicts reprogramming targets using signal flow analysis and feedback vertex set control, respectively. Through validations in studies of cell fate reprogramming from developmental, stem cell, and cancer biology, we show that NETISCE can predict previously identified cell fate reprogramming targets and identify potentially novel combinations of targets. NETISCE extends cell fate reprogramming studies to larger-scale biological networks without the need for full model parameterization and can be implemented by experimental and computational biologists to identify parts of a biological system relevant to the desired reprogramming task.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 University of Connecticut School of Medicine, Center for Quantitative Medicine, Farmington, USA (GRID:grid.208078.5) (ISNI:0000000419370394)
2 University of Connecticut School of Medicine, Center for Quantitative Medicine, Farmington, USA (GRID:grid.208078.5) (ISNI:0000000419370394); University of Connecticut School of Medicine, Department of Cell Biology, Farmington, USA (GRID:grid.208078.5) (ISNI:0000000419370394); University of Connecticut School of Medicine, Center for Cell Analysis and Modeling, Farmington, USA (GRID:grid.208078.5) (ISNI:0000000419370394); University of Connecticut School of Medicine, Institute for Systems Genomics, Farmington, USA (GRID:grid.208078.5) (ISNI:0000000419370394)